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Progenitor T cells undergo a complex differentiation process in the thymus, in
which theT cell repertoire in the periphery is created . After the initial rearrange-
ment ofTCR genes, at least two selection steps arethought to influence the further
development. Both involve interactions oftheTCR andMHCantigens (1-3) . During
the first process T cells bearing certain receptors are positively selected for further
development upon "proper" interaction with thymic MHC antigens. A number of
recent reports using chimeric mice (4), in vivo mAb treatment (5), or transgenic
mice methodology (6, 7) support this view.
A reduction of the TCR repertoire occurs in a second process termed negative
selection or tolerance (8, 9) . Here, T cells recognizing self antigens together with
selfMHC are functionally inactivated . The first evidence fora possiblemechanism
came from studies on the VS17aTCR (8) . We previously showed that TCRs con-
taining the Vfl17a element are eliminated during thymic development in IE+ mice,
at or after theCD4+ CD8+ double-positive stage . More recently, similar observa-
tions have been made in other selfantigen/TCR systems, such as Mls-1°with V#6
and Vfl8 .1 (10, 11), and Mls-2/3a with V03 (12) .
In mature T cells a close association exists between the expression of either the
CD4orCD8 surface moleculesand the ability to recognize antigen associated with
either class II or class I MHC molecules, respectively (13, 14) . Therefore, it was
surprising that in these tolerance experiments, despite the fact that the antigen in
each case was associated with class II MHC, deletion of CD8+ T cells was often
nearly as complete as that of CD4 + T cells .
There are two possible explanations for this phenomenon; either, tolerance to these
antigens occurs when thymocytes are immature and express CD4 andCD8 simul-
taneously ; or, alternatively, CD8+ mature T cells are able to recognize these class
II antigens and are subject to deletion . In the latter case, it should be possible to
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detect such a reactivity in vitro using hybridoma technology. However, the BW5147
(BW)' fusion partner for T cells does not support expression of CD8 after fusion
to CD8 + T cells, and hybrids made from these cells generally do not react with the
particular antigen under study (15). The recent cloning of the mouse CD8 molecule
(16, 17, and for a review, 18) makes this study now feasible.
To test these ideas for V017a' T cells, we generated CD8+ V017a' T cell hybrids
in two ways: first, previously established V017a' T cell hybrids, either CD4' or
CD4- , were transfected with a CD8 cDNA construct. Second, a new CD8+ fusion
cell line was established and used to generate a large number of V017a+ CD8+ T
cell hybrids. These hybrids were tested for their ability to recognize IE molecules.
In no case was any CD8-dependent IE reactivity found. Furthermore, the occasional
IE reactivity of Va17a' CD8+ hybrids was in nearly every case correlated with
derepressed CD4 expression. These results indicate that the propensity of T cells
bearing V017a to interact with IE is independent of the MHC class selecting the
cell, but that this interaction is highly dependent on the CD4 molecule. These findings
strongly support the view that tolerance to this antigen among CD8+ T cells occurs
at an early stage in the thymus when these cells bear CD4 as well as CD8.
In addition, we have demonstrated that a transfected CD8 molecule can function
in class I-restricted T cell hybrids, generated with a new CD8+ fusion partner. The
CD8 + cell line should prove useful for studying antigen processing requirements
of class I MHC-restricted T cells.
Materials and Methods
Mice.
￿
Mice were either bred in our own facility or purchased from TheJackson Labora-
tory Bar Harbor, ME. The production of the Vfl7a' B10 mouse strains indicated in Fig.
1 was described recently (19).
mAbs and Flow Cytometry.
￿
The mAbs used in this study are listed in Table I. For direct
immunofluorescence staining ofcells, mAbs KJ23a, 53-6.7, GK1.5, 145-2C11, and RG7/9.1
were labeled with FITC or biotin-n-hydroxysuccinimide. To detect biotinylated antibodies,
phycoerythrin-streptavidin (PE-Av; Tago Inc., Burlington, CA) was used as a secondary re-
agent. Cells were stained and analyzed using an Epics C flow cytometer (Coulter Electronics
Inc., Hialeah, FL) as previously described (20).
Cells.
￿
BWa- and BWa-S- are x-ray-induced derivatives of the BW5147 AKR thymoma
(33) that have lost the TCRQ or the a and0 genes, respectively (34). The chicken OVA (cOVA)-
specific T cell hybrid 2QO23-36.19.21 has been generated by immunizing SWR mice with
cOVA in the base ofthe tail. 1 wk later cell suspensions from inguinal, mesenteric, and cer-
vical lymph nodes (LNs) were prepared and T cells isolated by passage over a nylon wool
column (35). These cellswere stimulated in vitro for 4 d with antigen and SWR spleen cells.
For the generation of V017a' T cell hybrids, T cells were incubated on plates that had been
coated with mAb KJ23a (100 pg/ml purified antibody in PBS) overnight and washed several
times with MEM. After 1 h at 37°C, nonadherent cells were removed, the culture dish was
washed three times with medium, and adherent cells were incubated for 4 d in the presence
of IL-2 (200 U/ml). Subsequently, they were shaken off the plate, incubated another 2 d in
IL-2-containing medium, and fused to BWa- (36.19.21) or BWa-a- (3QO23-24.4). The fu-
sion was done as described (30). Both T cell hybrids recognize cOVA in conjunction with
IA9, as well as IE molecules of the k, s, and d haplotypes. The other IE-reactive hybrid,
2Q23-34.7 .10, is a CD4- derivative of 2Q23-34.7.9 that has been described previously (36).
I Abbreviations used in thispaper BW, BW5147; cOVA, chicken OVA; LN, lymph node; LTR, long ter-
minal repeat; neo, neophosphotransferase; PE-Av, phycoerythrin-streptavidin; SFFV, spleen focus-forming
virus; TB, transfection buffer.BURGERT ET AL.
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Transfections.
￿
The vector pSFSVn-Ly2a, used for expression of the CD8 molecule, was
kindly provided by Dr. J. Parnes (Stanford University, Stanford, CA). It consisted of the
Eco RI-Pvu II fragment of pBR322 containing the ampicillin resistance (AmpR) gene, the
SV40 promoter/enhancer region driving the selectablemarker gene, neophosphotransferase
(neo), followed by SV40 sequences with splice acceptor sites and poly(A) signals (37). Linked
to this portion of the plasmid is an Eco RI-Bam Hl fragment containing the Ly2a cDNA
flanked at the 5' end by the spleen focus-forming virus (SFFV) long terminal repeat (LTR)
and at the 3' end by SFFV` poly(A) signals. Transcription ofthe Ly2a DNA occurs in opposite
direction to the neo gene. The vector is essentially identical to one previously used for expres-
sion of the CD4 molecule, except that the CD4 cDNA was replaced by a CD8a cDNA (38).
Before transfection, the pSFSVn-Ly2a plasmid was cut with the restriction enzyme Nde
I. A corresponding restriction site is located close to the pBR322 origin of replication. DNA
was sterilized by ethanol precipitation and solubilized in H2O at a concentration of 31~g/ml.
5 x 106 T cells were washed once with HBSS and then with transfection buffer (TB) that
consisted of the following ingredients: 0.28 M glucose, 1 mM KH2 PO4/K2HPO4, pH 7.1,
0.1 mM calcium acetate, 0.5 mM magnesium acetate, and 50 Rg/ml freshly added BSA. Fi-
nally, cells were resuspended in 95 pl TB, 5 pl DNA (15 hg) was added, and the mixture
was incubated on ice for 10 min. Transfection was performed using an electroporator (2000;
Baekon, Inc., Saratoga, CA). The settings were as follows: 9 KV amplitude, 256 pulses, each
160 ps long. The burst time was 12 .8 s and the distance between electrode and the surface
of the transfection buffer was 3 mm. Seven cycles were carried out. Under these conditions,
50-80% of the cells died during transfection or within 24 h. After 10 min on ice, the cells
were resuspended in 120 ml of medium and plated in five 24-well plates (Becton Dickinson
& Co., Mountain View, CA). 40 h later the selective drug G-418 (Gibco Laboratories, Grand
Island, NY) was added to a final concentration of 800-1,500 ug/ml depending on the T cell
line transfected. The optimal concentration for each hybrid was determined before transfec-
tion. To control the efficiency of the drug, cells were mock transfected (without DNA) and
cultured in parallel. The medium was changed every 4-5 days. 2 wk aftertransfection, cells
of individual wells, mostly clonal, were analyzed for cell surface expression ofthe CD8 mole-
cule. In our hands, successful transfection of T cell hybrids required the particular TB used
in this study. Other buffers like PBS or HBSS did not result in any colonies.
Preparation ofResponder andStimulator Cellsfor MLR.
￿
Cells ofmesenteric, inguinal, brachial,
renal, and axillary LNs were pooled and enriched for T cells through a nylon wool column
(35). This cell preparation (12 x 10' cells) was incubated with 5 ml culture supernatant of
mAb GK1 .5 for 45 min at room temperature, washed three times, and then transferred to
two plastic dishes (75 cm2) precoated with goat anti-rat Ig antiserum (100 1~g/ml). Incuba-
tion was at 4'C for 45 min. This adsorption step was repeated twice. 3.4 x 101 nonadherent
CD8-enriched T cells were recovered, washed, and cocultured (2 x 106/ml) with splenocytes
of DBA/2 mice (4 x 106/ml) that had been pretreated with Gey's solution (39) to remove
erythrocytes, and irradiated with 2,000 rad. No IL-2 was added in order to prevent growth
of preactivated, nonspecific T cells (40). After 4 d T cell blasts were isolated by centrifugation
on a LSM cushion (Organon Teknika Corp., Durham, NC) and incubated for another 2 d
in medium supplemented with IL-2. Before fusion, the cellswere tested for CD8, CD4, and
Vf17a expression.
Fusion of CD8' T Cells with BWLyt2-4.
￿
The fusion was carried out essentially as described
previously (30), with the exception that 24 h later, HAT and G-418 (400 NAg/ml) were added
to select for CD8' hybrids. The concentration of G-418 was chosen to be low compared with
the drug concentration used for selection of the BWLyt2-4 fusion partner (700 Wg/ml) in
order to avoid additional stress to the growing hybrids. Sometimes this low concentration
of G-418 allowed the growth of CD8- cells (probably due to chromosome loss), which could
often be eliminated by increasing the G-418 concentration to 600-800 pg/ml.
IL-2Assay.
￿
IL-2 production ofT cell hybridomas was determined using the IL-2-dependent
cell line HT-2 as described previously (30). Briefly, 105 T cell hybrids were incubated with
106 splenocytes or 105 P815 cellsor B lymphoma cells in the presence or absence ofdifferent
mAbs. In antibody blocking experiments, mAbs were added either as 50,ul undiluted culture
supernatant or as 1 :100 diluted ascites fluid. The final volume of the cultures was always1890
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TABLE I
mAbs Used in This Study
250 pl. Stimulation ofT cell hybrids with mAbs against the TCR was achieved by coating
microtiter wells overnightwith aTCRspecific antibody (20). 24 hlater, 80 JAIofsupernatant
was transferred to a new microtiter plate, where serial dilutions were performed and HT-2
cells added. The amount ofIL-2 was assayed visually (30) and with the MTTELISA (41).
Results
Deletion of CD8' and CD4+ VS17a* T Cells in IE' Mice.
￿
V017a* T cells are
strongly reactiveto IEmolecules. This hasbeendemonstrated bydeletion ofmature
VS17a* thymocytes in IE f mouse strains, as well as by the overwhelming IE reac-
tivity ofV017a' CD4+ T cell hybrids (8, 18).
Fig. 1 illustrates the point that in IE* mice, both CD4+ and CD8* T cells bearing
VS17a were deleted. In these experiments, good expression ofVS17a* T cells was
seen on both CD4* or CD8' T cells in mouse strains lacking an IE molecule. On
the other hand, most V017a* T cells, including both CD4* and CD8' cells, were
deleted from IE* strains. For example, the percentage ofVa17a* CD4+ T cells in
B10.HTTOL (IE*) dropped by -90% compared with BIOS(7R)SL (IE-). A similar
reduction of-70% was observed in the CD8' V017a* T cell subset ofB10.HTTOL
(Fig. 1).
We performed a number of experiments to test the relative efficiencies of CD4
and CD8 to act as accessory molecules for IE recognition by VS17a* T cells in order
to distinguish whether tolerance to IE involves deletion ofCD8+ T cells at a CD4*
CD8' or a CD4- CD8' stage.
Effects ofMurine CD8a Transfectedinto V017a' TCell Hybrids.
￿
So far, the double-
positive thymocyte population is not directly accessible to functional tests. There-
fore, we decided to investigate the reactivity of VS17a' CD8' T cells in vitro. Up
to now, generation ofsuch cells using hybridoma technology was hampered by the
fact that expression ofthe incoming CD8 molecule was specifically shut down in
hybrids derived from the BW5147 fusion partner (15).
Wehoped to avoid this problem by transfectinginto T cell hybrids acDNA con-
struct of CD8a in which the potential 5' regulatory element was replaced with a
rnAb Relevant specificity Reference
KJ23a V017a 20
H57-597.2 TCR 21
145-2C11 T3e 22
53-6.7 CD8 23
GK1 .5 CD4 24
RG7/9.1 rat K 25
20-8-4 Kd, Kb, Qa 26, 27
30-5-7 Ld 28
34-5-8 Dd 28
142-23 Kk, Dk, Kb 29
34-1-2 Kd, Dd, s, Qa 27, 28
MK-D6 Ad 30
M5/114 Ad, Ed 31
Y17 Ek, Es 32BURGERT ET AL.
FIGURE 1 .
￿
Elimination ofV#17a*CD4' as well
as V,617a* CD8*T cells in the periphery of IE'
mice. The production of the mouse strains indi-
cated in the left panel has been described previ-
ously (19) . Nylon wool-purified LNT cells were
stained with either FITC-anti-CD4or FITC-anti-
CDS and biotinylated antiV#17a plus PE-Av .
strong viral promoter (see Materials and Methods for more detailed information) .
The purpose of this experiment was twofold, first, to test whether theCD8 cDNA
can be generally expressed in these cells and, second, whether CD8 can be used
as an alternative accessory molecule in order to recognize IE antigens . TwoVf17a+
T cell hybrids were chosen as transfection recipients : 2Q23-34.7.10, aCD4- variant
of a V017a+ hybrid (36), which retained a weak reactivity to IE after loss of theCD4
molecule; and 2QO23-36.19.21, aCD4+ VS17a+ hybrid, originally selected for re-
activity to cOVA/IA9, but also capable ofC134-dependent IE recognition . For sim-
plicity, we refer to these cell lines in the text as 34.7 .10 and 36.19.21. Both cell lines
FIGURE 2.
￿
Cell surface expression ofCD8moleculesupon transfection ofV1617a' Tcell hybrids .
Cells were stained with indirect immunofluorescenceusingmAbs FITC-RG7/9.1(BGD), KJ23a
(V,617a), GK1.5 (CD4), and 53-6.7 (CD8). KJ23a binding was detected by FITC-labeled goat
anti-mouse IgG serum and the rat antibodies against CD4and CD8by FITC-RG7/9 .1 . FACS
histograms areshownwith the green fluorescence (x-axis) as a 3 decadic log scale . The numbers
are the linearized mean value offluorescence. The number ofcells is plottedon they-axis . The
recipient cell lines for transfection, 34.7.10, 36.19.21, and one representative clone derived from
each transfection, areshown . The histograms are from the analysis of 5,000 (34.7.10 cell lines)
and 10,000 (36.19.21 cell lines) cells .
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were transfected by electroporation with the pSFSVn-Ly2a plasmid containing the
neo gene as selectable marker in addition tothe Ly2a cDNA. Fig. 2 shows the results
of a FAGS analysis from the parental cell lines and one ofeach transfectant. The
recipient cell lines 34.7.10 and 36.19.21 did not express CD8, whereas the two trans-
fectants 36.19.21Ly2-6 and 34.7.10Ly2-2 expressed highlevels ofthis molecule. The
amountofCD4 and TCR on the plasma membrane oftransfectantswas comparable
with the untransfectedcelllines. ExpressionoftheCD8 molecule was stable asindi-
cated by its unaltered expression after continuous culture of transfectants for 3 mo
without G-418 (data not shown). Thus, the cDNA construct gave rise to high and
stable expression of the CD8 molecule in T cell hybridomas.
We then tested whether or not the transfected CD8 molecule contributed to the
recognition ofIE molecules bythesehybrids. Hybrids were cocultured with B10.BR
spleen cells (IEk) in the presence and absence ofmAbs against CD4, CD8, IEk, and
K'D' molecules. As a readout system, IL-2 production was measured using the IL-
2-dependent cell line HT-2 (30). The response (U/ml IL-2) of the CD4- CD8'
34.7.10transfectantswas basicallythe sameasthat oftheuntransfectedcellline(Table
11). Neither CD8- nor CD4-specific mAbs inhibited IL-2 production. However, in-
hibition bythe mAb directed to IE indicated that the amount ofIL-2 produced de-
pended upon stimulation by IEmolecules and not by class I MHC molecules. This
wasconfirmed by thelackofsignificant IL-2 production when the hybridswere cul-
tured together with IE- B10A.(4R) spleen cells (data not shown).
Similar results were obtained comparing IL-2 production ofCD4+ CD8' 36.19.21
transfectants withthe recipientcell line. In this case, however, the mAb against CD4
completely inhibited the response, indicating that the CD8 molecule expressed in
the transfectants could notsubstitute forCD4in this recognition. Also, the response
of36.19.21 transfectants towards OVA/IA9 was unchanged compared with that of
TABLE II
CD8 Does Not Replace the Accessory Function of CD4 in
Transfected IE-reactive V,B17a* T Cell Hybrids
Recipient cell lines 2Q23-34.7.10 or 2Q023-36.19.21 and their CD8' derivatives were cocul-
tured with B10.BR spleen cells in the presence or absence of the following mAbs: anti-CD4,
GK1.5; anti-CD8, 53-6.7 ; anti-IEk, Y17 ; and anti-KkDk, 142-23. IL-2-containing superna-
tants were serially diluted on HT-2 cells and U IL-2 was determined as described (30). In this
assay, <10 was the smallest amount ofIL-2 to be detected. BIO.BR spleen cells alone produced
<10 U/ml of IL-2. Very similar results have been obtained from 12 more CD8' clones gener-
ated by the two transfections.
Cell
CD4
surface
expression
CD8
IL-2
Medium
produced
aCD4
upon stimulation by :
B10.BR spleen cells
cfCD8 aIE' ciK'D'
U/ml
2Q23-34.7.10 - - 160 120 160 20 160
2Q23-34.7 .IOLy2-1 - + 120 120 120 25 80
2Q23-34.7.IOLy2-2 - + 160 160 160 10 160
2QO23-36.19.21 + - 520 <10 200 25 480
2QO23-36.19.21Ly2-6 + + 400 <10 200 20 120
2QO23-36.19.21Ly2-10 + + 200 <10 110 10 80BURGERT ET AL.
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the untransfected cell line. Furthermore, none of the hybrids reacted with class I
antigens either expressed on P815 cells or L cells (data not shown). We concluded
that the CD8 molecule does not influence the reactivity of these hybrids to their
respective antigens. These data suggested that CD8 is not a functional accessory
molecule for these particular TCRs in recognition of the IE molecule or of the
cOVA/IA9.
Generation ofa New Fusion Cell Line Expressing CD8.
￿
However, one could argue
that, first, the two TCRs examined with this transfection technique were preselected
in the thymus together with CD4 and therefore might not be functional with CD8 .
Second, only a small number of TCRs (two) were tested; and third, we have not
presented evidence that the transfected CD8 molecule is functional at all in the BW5147
background.
As CD8 + T cells are restricted to class I MHC antigens, we tested the function
ofthe introduced CD8 molecule by generating class I-restricted T cell hybrids. This
was done in two ways. First of all, the CD8a cDNA construct was transfected into
the BWa-a-
fusion cell line (34). We hoped to use such a cell line as a fusion
partner for class I-restricted T cells. Transfection of BWa-a- with the CD8a cDNA
vector led to expression of CD8 at the plasma membrane, confirming that BW was
unable to downregulate the CD8 antigen when expressed from this construct (data
not shown). One of the CD8+ BW clones, BWLyt2-4, which expressed a high level
of CD8 (Lyt2a) on the cell surface, was chosen for further studies.
Generation ofClass I-restricted, Alloreactive T Cell Hybrids Using the CD8+ Fusion Cell
Line. Class I-restricted T cells were generated by a primary MLR using C57L
cells as responders and DBA/2 cells as stimulators. C57L mice were chosen because
they express V017a+ TCRs and because the C57 background seems to give good
alloresponses in primary MLR (40). Nylonwool-purified LN T cells were enriched
for CD8' cells by removal of CD4+ cells with panning. This procedure resulted in
a T cell population highly enriched for CD8 expression (>95%). This T cell prepa-
ration was incubated for 4 d with irradiated DBA/2 spleen cells. The isolated T cell
blasts were expanded for 2 more d in the presence of IL-2. Before fusion, T cell
blasts were examined using FAGS analysis. 98.4% were CD8 + , only 1.4% expressed
the CD4 marker, and 5.9% of T cells were V#17a+ . These T cells were fused to
BWLyt2-4. Hybrids were expanded and functionally analyzed measuring IL-2 produc-
tion. Table III summarizes the reactivity pattern obtained. Of the 29 hybrids tested,
four did not produce IL-2 upon stimulation with crosslinked anti-CD3 mAb, six
failed to react with either DBA/2 spleen cells or P815 cells, and for five, a weak IL-2
production was observed but a specificity could not be assigned. The reactivity of
14 hybrids could be identified. Three seemed to recognize class II molecules and
were not further studied; 11, however, reacted with class I molecules of H-2d cells.
To identify the particular class I molecule recognized, each hybrid was incubated
with P815 cells and DBA/2 spleen cells in the presence and/or absence ofmAbs against
individual H-2d gene products. In addition, the susceptibility of the T cell hybrids
to inhibition by CD4- and CD8-specific mAbs was tested. The analysis of three rep-
resentative hybrids is shown in Fig. 3 . BD8-5 recognized H-2Kd as indicated by
the specific inhibition of IL-2 production by mAb 20-8-4 directed against Kd (26).
This result was confirmed by stimulation of this hybrid with D2.GD but not with
B10A.(5R) spleen cells, expressing Kd , Ad, Db, and Kb, Ab, EM,
Ld, and Dd MHC1894
Total
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TABLE III
Reactivity Pattern of T Cell Hybrids Generatedfrom Alloreactive
T Cells and the BWLyt2-4 Fusion Partner
Reactivity pattern
No IL-2 production with anti-CD3
No reactivity to DBA/2 or P815
Reactivity not identified
Reactivity to class II MHC
Reactivity to class I MHC
T cell hybrids
4
6
5
3
11
29
T cell hybrids were produced with the BWLyt2-4 cell line as fusion partner as
described in Materials and Methods . To examine the general capability ofT
cell hybrids to produce IL-2 via theirTCR, cells were incubated on wells coated
with anti-CD3 mAb (22) . The IL-2 response was measured visually (30) and
with the MTT-ELISA (41) . Reactivities were identified by antibody blocking
studies as illustrated in Fig . 3 . In general, the response of hybrids whose reac-
tivity could not be assigned for was<20U/ml IL-2 when stimulated by DBA/2
splenocytes .
FIGURE 3 .
￿
The reactivity ofCD8* T cell hybrids can be
specifically blocked by class IMHC- and CD8-specific an-
tibodies. Three differentT cell hybrids derived from a fu-
sion of alloreactive CD8* T cells (primary MLR; C57L-
DBA/2) with BWLyt2-4 were incubated with DBA/2 spleen
cells only (-) or together with 50 pl ofcell culture superna-
tants of the following mAbs: ctKd (20-8-4), oiLd (30-5-7),
aDd (34-5-8),alAd (MK-D6), oCD4 (GK1.5), and aCD8
(53-6.7) . IL-2 production was monitored by titrating su-
pernatants onthe IL-2-dependent cell lineHT2 .The assays
were read visually and with an MTTdependent ELISA (41) .BURGERT ET AL.
molecules, respectively (data not shown). In similar fashion, the reactivity of the
other hybrids was identified (Fig. 3 and Table IV).
More important was the fact that the response of the vast majority ofclass I-re-
stricted T cellhybrids was inhibited by CD8-specific antibodies. A summary ofthe
data is shown in Table IV. Three class I-reactive clones (BD8-4, BD8-12, and BD8-
A5) did not express appreciable amounts of CD8 on the cell surface. Accordingly,
their IL-2 response could not be inhibited by anti-CD8 mAb. Allofthe CD8+ class
I-restricted hybrids (8/8) were inhibited by mAb 53-6.7 directed to murine CD8,
indicatingvery strongly thatCD8 serves as afunctionalaccessory molecule forthese
T cell hybrids. These experiments also demonstrated the general usefulness ofthe
BWLyt2-4cell line forgenerating classI-restrictedantigen-responsive Tcellhybrids.
In addition, a CD8- T cell hybrid derived from a TNP-specific, class I-restricted
T cell clone was transfected with CD8 and its function reconstituted (H.-G. Bur-
gert, unpublished results).
Generation and Reactivity towards FEMolecules of V#17a' CD8+ T Cell Hybrids.
￿
We
TABLE IV
The Introduced CD8 Molecule Is Functional in Class I-restricted,
Alloreactive T Cell Hybrids
Alloreactive T cell hybrids have been generated by a primary MLR (C57L -.
DBA/2) and subsequent fusion with the BWLyt2-4 cell line. Only those hybrids
are listed whose reactivity could be identified by antibody blocking studies.
The FACS data are given as linearized mean values of fluorescence, after stain-
ing cells with mAb H57-597.2, directed to a TCR framework determinant (21),
and with the anti-CD8 mAb, 53-6.7. The reactivity given was identified as
described in the legend to Fig. 3. The average amount of IL-2 produced by
a particular T cell hybrid is expressed as U/ml and is a mean value from three
to five independent experiments, taking into account the data from both P815
cells and DBA/2 spleen cells. The degree of inhibition by anti-CD8 mAb is
shown as: + + +, >80% ; + +, 55-80% ; +, 30-557o ; -, 0-300 1o inhibi-
tion. The latter is considered unspecific since CD8- T cell hybrids fall in this
category.
IL-2 (U/ml) after stimulation with DBA/2 cells only. These hybrids produced
much more IL-2 (4-20 times more) in response to DBA/2 splenocytes than
to P815 cells.
Data from one experiment.
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BD8-T cell hybrid
FAGS
TCR
analysis
CD8
Reactivity
average of IL-2
Inhibition
by anti-CD8
BD8-3 32 86 Kd 210 + + +
BD8-4 19 - Ld 570 -
BD8-5 45 140 Kd 590 + + +
BD8-8 22 98 Kd 10 +
BD8-9 16 71 Kd 17 +++
BD8-10 34 64 IAd 7' +
BD8-12 44 - Kd 290` -
BD8-14 19 112 Ld 1,470` + +
BD8-15 ND ND Dd 85I + + +
BD8-17 28 119 IAd 900` -
BD8-21 12 66 IAd 23' +
BD8-23 26 112 Dd 80' + +
BD8-A3 37 160 Kd 1,230' + +
BD8-A5 18 - Ld 700 -1896
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concluded that the introduced CD8 molecule was functional in the BWLyt2-4 cell
line and, therefore, one should be able to generate functional CD8+ Va17a' T cell
hybrids. To this end, CD8' V017a' T cells from SWR or B10.16J(19) mice were
stimulated to grow by culturing them on antiVol7a-coated plates. The resulting
T cell blasts were 98% positive for theCD8marker and 99% positive for KJ23 (data
not shown). After 2 more d in IL-2, T cell blasts were fused to BWLyt2-4. Large
numbers of T cell hybrids were obtained from both fusions (396 from SWR, 210
from B10.0J). Of those, 115 and 48, respectively, were tested for expression of CD8
and Va17a by two-color flow cytometry. The vast majority ofclones expressed both
antigens at least to some extent.
Only those hybridomas that were >90% positive for V017aand CD8 were exam-
ined functionally. 11 Tcell hybrids derived from C57BL/10.0J, and 27 derived from
SWR, referring to B and Q, respectively, were tested for their response to B10.A
(IEk), B10.HTT (IE'), and B10 (IE-) spleen cells. In addition, their general capa-
bility to produce IL-2 via their TCR was examined by incubation on KJ23-coated
wells. The amount of IL-2 produced is indicated in Table V.
Two T cell hybrids from each strain (B7, B24, Q35, and Q114) did not produce
IL-2 upon stimulation with the mAb againstV017aand were excluded from further
analysis. Surprisingly, only one of nine B10.BJ-derived T cell hybrids (B40) and 7
of the 25 SWR-derived hybrids seemed to react with IEk and/or IE3.
Contribution of CD4 and CD8 to IE Reactivity of Vl317a+ T Cell Hybrids.
￿
We fur-
ther investigated whether or not CD8 was involved in this recognition process by
antibody inhibition studies (Table VI). In general, the anti-CD4 and anti-CD8 anti-
bodies showed some nonspecific inhibitory activity that decreased the IL-2 produc-
tion of CD4- (eg., B40, Q120) or CD8- (3QO23-24.4) T cell hybrids when stimu-
lated by one or both types of spleen cells. For the CD4 antibody, we calculated this
to be 32%, forthe CD8-specific antibody, 41%. Taking these nonspecific effects into
account, none of the IE-reactive hybrids was significantly inhibited by the anti-CD8-
specific antibody, indicating that the CD8 molecule did not act as accessory mole-
cule for IE recognition. Surprisingly, however, four ofthe six SWRderived hybrids
produced reducedlevels of IL-2 in the presence ofthe anti-CD4 antibody. We there-
fore analyzed whether or notthesehybrids expressed CD4. All four clones inhibited
by the C134-specific: antibody contained avariable proportion ofcells (17-90%) positive
fortheCD4 molecule (datanotshown). Moreover, double staining experiments showed
that CD4 and CD8 were expressed on the same cell. Fig. 4 shows representative
data ofthe FACS analysis. The controlcell lines, BWLyt2-4 and 3QO23-24.4, were
CD8+ and CD4', respectively, indicated by the signal distribution pattern. Q2, an
IE-nonreactive T cell hybrid, and Q120, an IE-reactive one, did not express CD4.
However, the CD4-inhibitable T cell hybrids Q10, and especially Q25, contained
a proportion of cells (22 and 68% in this experiment) that coexpressed CD4 and
CD8. Similar results were obtained for the other CD4-inhibitable T cell hybrids
(Q15, 22%; Q129, 3%). Apparently, CD4 had become derepressed in these partic-
ular hybrids, an observation made previously by Carboneet al. (15) studying hybrids
produced by fusion of CD8' T cells to BW5147.
In summary, five of seven IE-reactive T cell hybrids(71%) expressed CD4 to var-
ious degrees. As these expression data correlated with the inhibition experiments,
we attributed the IE reactivity to the expression of CD4. A similar high percentageBURGERT ET AL.
TABLE V
Only a Small Percentage of ,817a' CD8' TCell Hybrids
Responds to IE Molecules
T cell hybrids derived from the fusion of BWLyt2-4 of either 1310.#J CD8'
VS17a' T cells (131-1351) or CD8' V,817a' SWR T cells (Q2-Q135) were
stimulated by spleen cells or the mAb against V817a (KJ23a). IL-2 response
was measured as before (see Table III). In this assay the background IL-2 produc-
tion of BlO.A, B10.HTT, and B10 spleen cells was 5, 6, and 4 U/ml, respec-
tively. T cell hybrids that had IL-2 responses <10 were considered nonresponsive.
III, B51, and Q3 were subsequently shown to be nonresponsive. The CD4'
Vfl17a' T cell hybrid 3QO23-24.4 was used as a positive control; its produc-
tion is described in Material and Methods.
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T cell hybrid 1310.A
IL-2 produced upon
BlO.HTT
stimulation by:
1310 KJ23a
U/ml
BWLyt2-4 10 12 11 2
3QO23-24.4 1,210 2,570 23 2,630
131 7 15 3 1,330
B7 2 2 1 3
1313 4 5 5 144
1316 5 5 7 1,740
1323 5 6 4 170
1324 4 6 3 3
1327 6 9 6 260
1332 7 3 3 80
1338 7 5 3 130
1340 390 26 4 3,460
1351 11 8 3 1,630
Q2 8 9 3 1,720
Q3 9 12 ND 70
Q5 8 32 3 960
Q6 6 8 5 2,420
Q10 40 16 3 750
Q14 6 5 4 270
Q15 20 70 6 1,830
Q17 8 6 5 340
Q22 4 7 4 450
Q25 110 230 4 1,290
Q30 6 4 4 80
Q33 2 2 1 1,620
Q35 3 2 3 5
Q50 4 2 2 180
Q56 2 3 3 190
Q62 5 7 ND 770
Q68 2 1 2 160
Q73 3 1 2 63
Q85 5 3 2 53
Q108 6 10 3 970
Q114 2 6 3 3
Q120 9 40 2 1,870
Q125 2 1 2 960
Q129 13 150 2 270
Q131 3 3 5 1,080
Q134 3 5 3 1,320
Q135 4 9 1 180
No hybrid 5 6 4 ND1898
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TABLE VI
Frequent Inhibition of IE Reactivity by Anti-CD4-specific Antibodies
The indicated T cell hybrids were cocultured with B10.A and B10.HTT spleen cells with or
without soluble mAbs against CD4 (GK1 .5), CD8 (53-6 .7), IE (Y17), KkDk (142-23), and
H-2' (34-1-2) . The anti-CD4- (33%) and anti-CD8- (41%) specific mAbs affected the IL-2
response nonspecifically given the data from cells that did not express CD4 (eg ., B40, Q120)
or CD8 (3QO23-24 .4) . mAb 142-23 recognizes only oneMHC class I antigen on B10.A spleno-
cytes . Basically, the same results were obtained when, in addition, anti-Ld and anti-Dd mAbs
were used . The amount of IL-2 was determined as described in Table III . Background IL-2
production of B10.A and B10.HTT splenocytes was subtracted .
(60-90%, dependingon themouse strain) of IE reactivity was foundpreviously among
V017a+ CD4* T cell hybrids (20) . In contrast, we found only one hybrid from each
fusion (B40 and Q120) that wasIE reactive but notinhibitedby either CD4- or CD8-
specific antibodies . These two hybrids were considered to have high affinity TCRs
for IE molecules that were not dependent on the help of accessory molecules . Thus,
overall, we did not find any hybrid whose IE reactivity was inhibited by anti-CD8,
FIGURE 4. Many IE-reactive T cell hybrids express
boththeCD4 and the CD8 molecule at the cell surface.
Two-color fluorescence histograms of control cell lines
3Q023-24 .4 (VO17a*, CD4* CD8 - ), BWLyt2-4 (CD4-
CD8*) and different V017a+ CD8* T cell hybrids are
shown . The cells were incubated with biotinylated GK1 .5
mAb and then withPE-Av and FITC-labeled53-6-7 an-
tibody. The gates were set after analysis ofthe controls .
TheTcell hybrids Q2, Q10, Q25, and Q120 were gener-
ated by fusing BWLyt2-4 with CD8* V,617a* T cells of
SWR mice. Q2 does not recognize IEmolecules, whereas
the three latter ones do. The percentages of CD4* CD8*
cells in the other IE-reactive clones not discussed in the
text were: 4% (Q5), 22% (Q15), and 2.4% (Q129) . These
values had considerably decreased since the first FACS
experiment was done. At that time the proportion of
CD4*CD8` cells was as follows: Q5, 17% ; Q10, 35% ;
Q15,58% ; Q25,97% ; Q120, 0% ; Q129,19% ; B40, 0%) .
IL-2 produced upon stimulation with :
T cell
hybrid - ctCD4
B10 .A
aCD8 aIE oKkDk - ctCD4
B10.HTT
aCD8 aIE al-1-2 1
3QO23-24 .4 1,080 4 480 60 610 2,570 70 1,880 430 2,840
B40 260 260 250 30 140 30 8 19 0 21
Q5 3 2 1 0 0 34 17 23 0 27
Q10 26 4 26 2 24 16 0 12 1 15
Q15 14 0 5 0 3 50 0 34 0 31
Q25 70 1 60 11 19 260 21 140 40 250
Q120 4 1 3 0 4 43 29 18 0 20
Q129 8 2 13 ND ND 240 110 135 ND NDBURGERT ET AL.
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and we therefore conclude that CD8 does not contribute to the recognition ofIE
molecules in vitro by these T cells.
Discussion
V#17a'-containing T cells exhibit a strong affinity towards IE molecules and an
unknown, probablyB cell-specific, selfantigen(20, 36). In mice expressingthisligand,
V017a' cells are clonally deleted during development in the thymus (8). In the pe-
riphery of IE' mice, Vf17a expression is reduced in both the CD4' and CD8+ T
cell subsets (19, and Fig. 1). This result prompted us to investigate directly the reac-
tivity ofCD8+ VS17a' T cells. To obtain such cells we transfected either established
CD4- and CD4', V#17a' Tcell hybrids, or an a-/3- derivative ofthe BW5147 T
cell fusion partnerwith an expressibleCD8a (Lyt-2a) gene. CD8was thus expressed
on the surfaces of the preexisting T cell hybrids (Fig. 2), and on hybridomas pro-
duced by fusion ofVa17a' CD8+ T cells to the CD8+ BW derivative (BWLyt2-4).
Interestingly, expression of CD8 in the preestablished V017a' hybridomas did
not alter their reactivity to IE molecules (Table II). Moreover, the V#17a' CD8+
hybrids derived from the fusion with BWLyt2-4 were mostly IE nonreactive (Table
V), and for those that did have some IE reactivity, this response was not inhibited
byanti-CD8 antibodies (Table VI). Thus, CD8 seems notto contribute toIEreactivity.
It is well established that CD4 and CD8 can bind directly to class II and class
I MHC proteins, respectively (42, 43). Since the target cells used in our assays ex-
pressed both IE and class I molecules, we expected that additional expression of
the CD8 molecule on the effector T cells would increase the overall avidity of the
T cell/target cell interaction, and thereby lead to increased IL-2 production. We
did not, however, detect an increased response, nor did we observe any additional
reactivities on the part of the T cell hybrids to, for example, class I antigens.
It is possible that one or the other ofthe interacting molecules was not expressed
at high enough levels in this system. We think this is unlikely, since genuinely class
I-reactive T cell hybridomas produced by fusion ofalloreactive T cells to the CD8+
BW derivative did use the CD8 as an accessory molecule. Alternatively, the affinity
for IE of the a/fl receptors on the previously established V#17a' hybridomas,
34.7.10 and 36.19.21, might have been high enough that the contribution from CD8
remained undetected. Rather, the opposite is probablytrue forthemajority ofhybrids
that were produced by fusion to CD8+ V,617a' T cells, cells that had presumably
been selected in the thymus for class I reactivity. Another possibility was that in
spite ofthefactthatthesecells boreVol7a, the rest ofthe components oftheirTCRs
precluded IEreactivity. We think this is an unlikelyexplanation because anyofthese
hybrids that were orbecame CD4' did manifest CD4-dependent IE reactivity. For
the two preexisting hybridomas that were transfected, one could argue that since
these hybrids were originally CD4', their receptors had been selected in the thymus
to operate with CD4, and could not properly interact with CD8. We feel that the
fact that our findings apply both to these hybrids, and to hybridomas made by fu-
sion to CD8' cells, argues against this possibility.
It is more likely that these data reflect the idea that CD4 and CD8 are closely
associated with the TCR in some way, and are able to contribute to the reactivity
ofTcells for their targets more efficiently if the target molecule, class I or class II,
forthe TCR is the same as that for the operative accessory molecule, CD8 or CD4.1900
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If this idea is correct, it follows that the TCR and CD8 can interact with the same
class I molecule, a view that is supported by the fact that CD8 binds to a region
ofclassImolecules, the0domain, with whichTCRs arenot thought to react(44, 45).
This idea has been suggested by much work in the past (13, 14, 46-49). Fazekas
de St. Groth et al. (46), forexample, isolated twoclass II-specific T cell clones bearing
both CD4 and CD8, and showed that only CD4contributed to antigen recognition
by these cells. Our results with the CD4+ CD8+ V017a+ cells corroborate these
findings. Also, the idea hasbeen given momentum from antibody-induced comodu-
lation andcrosslinking data that provideevidence foran association between CD4/CD8
andTCRs (47-49). However, there are otherexperiments that have shown that the
inappropriate accessory molecule can also play a role in reactivity (50-52). For ex-
ample, we have previously shown that CD4/class II interactions can stimulate the
reactivity for class I of the mouse T cell hybridoma, 3DT52.5 (50, 52), and Rat-
nofsky et al. (51) have similarfindings expressing humanCD8 in mouseT cell hybrids
specific for human HLA-DR antigens. Whether these represent special cases, or
some lapse in the system, in which nonhomologous interactions can contribute under
certain circumstances(e.g., suboptimal stimulation) to T cell/target binding, remains
to be seen.
Overall, these findings suggest that CD4- CD8+ V017a+ T cells recognize IE
rarely. Unless induction of tolerance by clonal deletion is much more sensitive to
low concentrations of antigen than is T cell stimulation, we can only account for
the deletion of CD8} and CD4+ cells at the CD4+CD8+ thymocyte stage. Other
experiments have shown that deletion at this stage is likely. Fowlkes et al. (53), for
example, showed that they could block the elimination of V017a' CD8+ T cells in
IE+ mice by treatment in vivo with an anti-CD4 antibody. Similar conclusions have
been reached from the study of TCR transgenic mice or of thymocyte development
in normal mice expressing superantigens (9, 54).
In the experiments described in this paper, we have expressed by DNA-mediated
gene transfer, the CD8a (Lyt-2cx) gene, but thymocytes and peripheral T cells ex-
press also CD8a (Lyt-3). One could argue that additional expression of CD80 might
add to the IE reactivity of the hybrids. Transfection of CD8a was sufficient, how-
ever, to allow C138-dependent reactivity of the class I-specific hybridomas (Table
IV, Fig. 3), and, moreover, restored reactivity to a preexisting CD8-, class I-re-
stricted T cell hybridoma (data not shown). Other investigators (55, 56) have also
found that transfection with CD8a was sufficient to restore CD8-dependent class
I reactivity. In fact, subsequent examinationof the BWLyt2-4-derived T cell hybrids
revealed that, similar to the physiologic situation, the great majority actually ex-
pressed the CD80 molecule. This impliesthat the incoming CD80 is regulateddiffer-
ently than the incoming CD8a molecule, expression of which is suppressed by BW
(15). It will be interesting to determine the basis for this differential regulation.
Finally, in this paper we have described the production and properties of a CD8+
fusion partner that can be used in the production of CD8-dependent T cell hybrid-
omas. CD8 expression by the BW derivative and hybridomas produced by fusion
to it is stable, providing levels of G-418 are kept sufficiently high during the critical
phase of hybridoma establishment. Hybridomas produced by fusion of the line to
class I-specific, alloreactive Tcells were functional and dependent upon the activity
of the CD8 molecules they bore. The specificity of these hybrids could be assayedWe thankJane Parries for the kind gift ofplasmid pSFSVn-Ly2cx. We further acknowledge
Drs. R. Kubo, J. Bluestone, and T. Potter fortheir generous giftsofmAbs H57-597.2, 145-
2C11, and 30-5-7, respectively, andDr. M. Blackman forcritical reading ofthe manuscript.
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witheaseusing theIL-2 assay. Sincethisreadoutsystem doesnot depend uponliving
cells, all the experiments done with CD4+ T cell hybrids and fixed target cells (57)
or isolated MHC class I molecules(58) should nowbe possible with class I-restricted
hybrids too. We hope, therefore, that the BWLyt2-4 cell line will help us to gain
further insight into the antigen processing and presentation requirements ofclass
I-restricted T cells.
Summary
Tolerance to IE molecules leads to deletion of Va17a-bearing T cells. Both, the
CD4+ as well as the CD8+ T cell subsets are affected. A large percentage ofCD4+
Va17a' T cell hybrids recognize IE molecules. We now have investigated the reac-
tivity for IE antigens of CD8+ V017a' T cell hybrids. Using a transfection ap-
proach, we have introduced the murine CD8 molecule into different V017a' T cell
hybrids. Furthermore, the CD8 cDNA was transfected into the BW5147a-(3- fu-
sion partner. This allowed us to generate a large number ofV017a' T cell hybrids
by fusion with the appropriate T cells. Only 6% ofT cell hybrids were stimulated
to produce IL-2 upon incubation with IE+ cells. However, in those, the CD8 mole-
cule seemed not to contribute to the IE reactivity ofthe hybrid, since mAbs against
the CD8 molecule failed to inhibit their reactivity. This low percentage ofV017a'
CD8+ IE-reactive T cell hybrids contrasts with the strong reduction of CD8+
V017a' T cells in IE+ mice, strongly suggesting that elimination of such cells in
thethymus occurs when they are coexpressing CD4 and CD8. Thisviewwasconfirmed
by the occasional expression of CD4 in some hybrids in which case IE reactivity
was detected. Furthermore, we demonstrated the functional integrity of the intro-
duced CD8 moleculeby: (a)reconstitution ofthe IL-2 responsein aclass I-restricted
TNP-specific Tcell hybrid; and (b) by generation of alloreactive class I-restricted
T cell hybrids using the new CD8+ fusion cell line. This CD8+ fusion partner,
BWLyt2-4, should prove useful to study antigen processing and antigen presenta-
tion requirements of class I-restricted T cells.
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